Comparison
3 Methylglutaconic Aciduria C3696376 vs 1p21 3 Microdeletion Syndrome
Clinical comparison between 3 Methylglutaconic Aciduria and 1p21 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
3 Methylglutaconic Aciduria C3696376
0-10
1p21 3 Microdeletion Syndrome
0-null
Onset patterns differ
Severity
3 Methylglutaconic Aciduria C3696376
severe
1p21 3 Microdeletion Syndrome
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria C3696376
Chronic
1p21 3 Microdeletion Syndrome
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria C3696376
No
1p21 3 Microdeletion Syndrome
No
Different transmission
Body System
3 Methylglutaconic Aciduria C3696376
metabolic
1p21 3 Microdeletion Syndrome
congenital
Same/different system
Category
3 Methylglutaconic Aciduria C3696376
metabolic
1p21 3 Microdeletion Syndrome
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-C3696376 and 1p21-3-microdeletion-syndrome-C4304578 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria C3696376 | 1p21 3 Microdeletion Syndrome | Discriminating power |
|---|---|---|---|
| Metabolic decompensation | May include acidosis or neurologic worsening during illness; pattern is not uniform. | Not established as a typical metabolic crisis from supplied data. | Moderate |
| Developmental features | Neurologic involvement can occur, but severity varies widely. | Congenital developmental effects are plausible but not specified here. | Low |
| Onset | Reported onset range is childhood, from birth through age 10. | Onset is listed as congenital, but the upper age is not established. | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria C3696376 when
Abnormal organic-acid findings
The concept concerns abnormal 3-methylglutaconic acid accumulation rather than a chromosomal deletion.
High
Metabolic illness pattern
Multisystem metabolic involvement and variable severity fit the supplied description.
Moderate
ICD-coded organic aciduria
The supplied code E71.111 supports this metabolic classification.
Moderate
Choose 1p21 3 Microdeletion Syndrome when
Chromosomal microarray result
A confirmed 1p21.3 deletion would point toward the genetic syndrome rather than aciduria.
High
Congenital presentation
The supplied axis classifies it as congenital and genetic.
Moderate
No metabolic evidence
Absence of supporting metabolic findings makes aciduria less likely, but does not prove the deletion.
Low
How key tests differ
| Test | 3 Methylglutaconic Aciduria C3696376 | 1p21 3 Microdeletion Syndrome | Interpretation |
|---|---|---|---|
| Urine organic acids | May show elevated 3-methylglutaconic acid; exact cutoffs are not supplied. | No characteristic organic-acid result is established. | An abnormal result supports metabolic evaluation but is not itself a complete diagnosis. |
| Chromosomal microarray | No specific chromosomal deletion is established by the supplied data. | A 1p21.3 microdeletion would be the defining finding if confirmed. | Genetic confirmation should be interpreted by a clinician or genetics specialist. |
| Metabolic blood tests | Acid-base or metabolic abnormalities may occur, without specified thresholds. | Expected abnormalities are not established. | Results require clinical correlation and should not be overinterpreted. |
Prognosis comparison
3 Methylglutaconic Aciduria C3696376
- Outcome
- Chronic course with widely variable severity; exact survival is not established.
- Factors
- Neurologic involvement, metabolic stability, and supportive care may influence course.
1p21 3 Microdeletion Syndrome
- Outcome
- Listed as chronic and moderate, but individual prognosis is not established.
- Factors
- Deletion confirmation, developmental findings, and associated anomalies may matter.
Time frame: Long-term; precise milestones are not supplied.
Diagnosis confirmation and clinical severity are the main available factors.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic complications | Brain involvement is described, with widely variable severity. Specific neurologic complications are not established. Neither condition has a definitive complication profile in the supplied source. |
| Metabolic crises | Illness-related metabolic worsening may require supportive care. Metabolic crises are not established. Management details and doses are not provided and should not be inferred. |
| Multisystem effects | Multiple body systems may be affected. Congenital effects are possible, but affected systems are unspecified. Individual assessment is necessary because source descriptions are limited. |
Patient education highlights
- HighDifferent causes
One is a metabolic disorder and the other is a chromosomal condition; they are not interchangeable diagnoses.
- HighSpecialist interpretation
Abnormal laboratory or genetic findings need clinician review before a diagnosis is assigned.
- MediumVariable course
Severity and long-term effects can vary, and exact outcomes are not established here.